No price history available.
Key financial summary
Financials in DKK| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | DKKm | 42 | 72 | 111 | 191 | 227 | 245 | N/A | N/A |
| Operating profit | DKKm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | DKKm | 5 | 8 | 11 | 12 | 8 | 0 | N/A | N/A |
| EPS reported | DKK | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | DKK | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | DKK | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | DKK | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | DKKm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | DKKm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | DKKm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | DKK | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | DKK | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in DKK| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Scandinavian Medical Solutions A/S (SMS), a global entity established in 2018 and headquartered in Aalborg, Denmark, specializes in medical imaging equipment. The company provides a comprehensive array of diagnostic and therapeutic devices, encompassing CATH lab systems, CT scanners, linear accelerators, mammography units, PET/CT and SPECT/CT systems, X-ray machines, ultrasound equipment, MRI scanners, GAMMA/SPECT systems, C-arms, mobile X-ray units, R/F systems, and DEXA scanners, among others. Furthermore, SMS supplies critical spare parts for specific equipment types including CT, MRI, CATH lab, X-ray, mammography, PET/CT, and C-arm systems. Beyond sales, their offerings extend to equipment rental and technical support services. SMS serves a broad clientele, including hospitals, various medical clinics, and distributors worldwide.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Scandinavian Medical Solutions A/S (SMSMED.CO)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Scandinavian Medical Solutions A/S (SMS), a global entity established in 2018 and headquartered in Aalborg, Denmark, specializes in medical imaging equipment. The company provides a comprehensive array of diagnostic and therapeutic devices, encompassing CATH lab systems, CT scanners, linear accelerators, mammography units, PET/CT and SPECT/CT systems, X-ray machines, ultrasound equipment, MRI scanners, GAMMA/SPECT systems, C-arms, mobile X-ray units, R/F systems, and DEXA scanners, among others. Furthermore, SMS supplies critical spare parts for specific equipment types including CT, MRI, CATH lab, X-ray, mammography, PET/CT, and C-arm systems. Beyond sales, their offerings extend to equipment rental and technical support services. SMS serves a broad clientele, including hospitals, various medical clinics, and distributors worldwide.